ProfileGDS4132 / 215316_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 24% 19% 28% 32% 25% 26% 25% 26% 29% 22% 31% 30% 30% 35% 46% 29% 32% 26% 32% 28% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10155.751824
GSM201543Muscle PCOS pioglitazone 12135.677919
GSM201544Muscle PCOS pioglitazone 16171.513728
GSM201545Muscle PCOS pioglitazone 20186.553732
GSM201829Muscle PCOS pioglitazone 23161.838825
GSM201830Muscle PCOS pioglitazon 25163.540426
GSM201831Muscle PCOS pioglitazone 27155.118625
GSM201832Muscle PCOS pioglitazone 3162.623626
GSM201833Muscle PCOS pioglitazone 4166.61229
GSM201834Muscle PCOS pioglitazone 8148.674222
GSM201835Muscle PCOS after pioglitazone 10263.698631
GSM201836Muscle PCOS after pioglitazone 12263.480830
GSM201837Muscle PCOS after pioglitazone 16261.196130
GSM201838Muscle PCOS after pioglitazone 20278.048435
GSM201839Muscle PCOS after pioglitazone 232113.80346
GSM201840Muscle PCOS after pioglitazone 25267.559329
GSM201841Muscle PCOS after pioglitazone 27265.434932
GSM201842Muscle PCOS after pioglitazone 3248.719826
GSM201843Muscle PCOS after pioglitazone 4278.564832
GSM201844Muscle PCOS after pioglitazone 8263.843528